Chemistry:AZD9272

From HandWiki
Short description: Medication
AZD 9272
AZD9272 structure.png
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H6F2N4O
Molar mass284.226 g·mol−1
3D model (JSmol)

AZD 9272 is a drug which acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR5.[1] It was unsuccessful in human trials as an analgesic,[2] but continues to be widely used in research especially as its radiolabelled forms.[3][4][5][6]

See also


References

  1. "Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development". Bioorganic & Medicinal Chemistry Letters 22 (22): 6974–6979. November 2012. doi:10.1016/j.bmcl.2012.08.100. PMID 23046966. 
  2. "Evaluation of the effects of a metabotropic glutamate receptor 5-antagonist on electrically induced pain and central sensitization in healthy human volunteers". European Journal of Pain 17 (10): 1465–1471. November 2013. doi:10.1002/j.1532-2149.2013.00327.x. PMID 23650072. 
  3. "AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects". The Journal of Pharmacology and Experimental Therapeutics 350 (2): 212–222. August 2014. doi:10.1124/jpet.114.215137. PMID 24876235. 
  4. "The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain". Neuropharmacology 135: 455–463. June 2018. doi:10.1016/j.neuropharm.2018.03.039. PMID 29608920. 
  5. "The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans". Neuropharmacology 162: 107809. January 2020. doi:10.1016/j.neuropharm.2019.107809. PMID 31589885. 
  6. "Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: 18F-AZD9272". ACS Chemical Neuroscience 11 (7): 1048–1057. April 2020. doi:10.1021/acschemneuro.9b00680. PMID 32167745.